Skip to content
Disclosery

EXANE DERIVATIVES: FTCHQ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FTCHQ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 20,380 FTCHQ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 20,380 shares
    Change vs previous 13F +4,701 shares

    0.08% of the 13F portfolio, value $145,894.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 15,679 shares
    Change vs previous 13F +4,668 shares

    0.07% of the 13F portfolio, value $237,052.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 11,011 shares
    Change vs previous 13F -3,195 shares

    0.09% of the 13F portfolio, value $368,082.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 14,206 shares
    Change vs previous 13F +5,136 shares

    0.13% of the 13F portfolio, value $532,422.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,070 shares
    Change vs previous 13F +3,684 shares

    0.11% of the 13F portfolio, value $453,308.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 5,386 shares
    Change vs previous 13F -2,320 shares

    0.09% of the 13F portfolio, value $285,551.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 7,706 shares
    Change vs previous 13F +906 shares

    0.15% of the 13F portfolio, value $491,697.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 6,800 shares
    Change vs previous 13F not available

    0.06% of the 13F portfolio, value $171,079.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).